MedTech analysis

Orthobiologics for Bone Repair and Regeneration

Sales of orthobiologics for the repair and regeneration of bone totaled nearly $2.4bn in 2018, with sales expected to climb at a CAGR of 3.2% through 2024. Growth in this market will be driven by the aging of the population and the global burden of musculoskeletal disease.

March 5, 2020

Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices

This comprehensive medical market and technology report provides an overview and in-depth market analysis of devices used in the treatment of peripheral vascular disease (PVD), including peripheral arterial disease (PAD) of the lower extremities; and deep vein thrombosis (DVT) and pulmonary embolism (PE).

May 28, 2020

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

This report provides an overview of primary neurological diseases/disorders treated with deep brain stimulation (DBS) and vagus nerve stimulation (VNS), as well as overviews of DBS and VNS neuromodulation technologies, competitors, sales, forecasts, and competitive and market analysis. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets.

May 26, 2022

Spinal Motion Preservation Devices Market

Sales of spinal motion preservation devices totaled $1.7bn in 2019, with sales expected to climb at a CAGR of 2.0% during 2019-2024.

May 18, 2022

Biomedtracker / Meddevicetracker Q3 2020 Outlook Report

In this report, we cover catalysts from 27 drugs, devices, diagnostics and deals expected to occur in Q3 2020. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

July 1, 2020

Neuromodulation: Spinal Cord Stimulation Devices Market

According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.

February 22, 2022

Drug Delivery: Infusion Devices – August 2020

This report provides a discussion of current/forecast markets, competitors, and opportunities in the global infusion drug delivery devices market, including the volumetric, syringe, ambulatory, disposable, implantable, and enteral pumps segments. Geographic regions covered include the US, five major European markets, Japan, and Rest of World markets; the forecast period is from 2019–24.

August 14, 2020

Spinal Fusion: Implanted Instrumentation

Sales of implanted instrumentation for spinal fusion procedures totaled approximately $4.4bn in 2019, with sales expected to climb at a CAGR of 2.2% through 2024. Growth in the spinal fusion instrumentation market is being driven by several factors including the prevalence of degenerative disc disease, new surgical techniques and associated instrumentation that have expanded the range of product indications, and the launch of new enabling technology such as diagnostic, nerve monitoring, and navigation systems (including robotic-assisted surgery).

August 20, 2020

Molecular Diagnostics Market

Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening and to a number of emerging applications in other diseases. The global market for molecular diagnostics is expected to grow at a CAGR of 10.8% between 2019 and 2024, reaching a value of more than $12bn.

September 30, 2020

Biomedtracker Q4 2020 Outlook Report

In this report, we cover catalysts from 35 drugs, devices, diagnostics, and deals expected to occur in Q4 2020. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

October 9, 2020

Hip Replacement Implants Market

An aging global population and increasing life expectancy are driving growth in the global market for hip replacement implants. This market is expected to grow at a CAGR of 2.1% over the forecast period, reaching a value of nearly $7bn in the year 2024.

October 22, 2020

Neurointervention: Mechanical Thrombectomy Devices Market

This medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and arteriovenous malformation (AVM) embolization systems.

October 30, 2020

2020 Post-ESMO Report

The Annual European Society for Medical Oncology (ESMO) 2020 Congress was held virtually from September 19 to September 21, 2020 due to the COVID-19 pandemic.

October 5, 2020

Knee Replacement Implants Market

This medical market and technology report provides a comprehensive discussion of the global market for knee replacement implants. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.

November 18, 2020

Extremity Replacement Implants

This medical market and technology report provides a comprehensive discussion of the global market for extremities replacement implants. Market forecasts and competitive analyses are provided for the shoulder, elbow, ankle, and small joint arthroplasty devices markets. Geographic segments covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets, which includes all other countries.

December 21, 2020

Respiratory Care: Noninvasive Ventilation and Airway Management Products

Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).

December 17, 2020

Diabetes Management: Insulin Pumps Market (2020)

This report provides an overview of diabetes, automated insulin pump systems, and a comprehensive market and competitive analysis.

December 30, 2020

Biomedtracker Early 2021 Outlook Report

In this report, we cover catalysts from 28 drugs, devices, diagnostics, and deals expected to occur in early 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

February 1, 2021

Arthroscopy Products and Sports Medicine Fixation Implants (2021)

This Meddevicetracker report provides an analysis of the market for arthroscopy products (including visualization systems, fluid management equipment, and manual and powered instruments) and sports medicine/soft tissue fixation implants for the US, five major EU markets, Japan, and the rest of the world.

March 18, 2021

Diabetes Management: Blood Glucose Monitoring Devices Market (2021)

This report provides a detailed presentation of diabetes and blood glucose monitoring devices, including standard fingerstick-based blood glucose meters (BGMs) and new sensor-based continuous glucose monitoring systems (CGMs) that attach to the body and monitor blood glucose 24 hours a day

March 31, 2021

Respiratory Care: Mechanical Ventilators and Pulmonary Function Testing Systems

Asthma and COPD affect an estimated 590 million people worldwide, with an additional 114 million affected by COVID-19 from March 2020 to March 2021. Devices used in the diagnosis and treatment of these and other respiratory disorders include mechanical ventilators and pulmonary function testing systems.

March 30, 2021

Biomedtracker / Meddevicetracker Q2 2021 Outlook Report

In this report, we cover catalysts from 28 drugs, devices, diagnostics, and deals expected to occur in early 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

April 1, 2021

Surgical Heart Valve Repair and Replacement Devices

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the surgical heart valve repair (annuloplasty) systems and surgical heart valve replacement products markets for the US, 5 Euro (France, Germany, Italy, Spain, and UK), Japan, and Rest of World markets from 2020–25.

June 28, 2021

Point of Care Diagnostics

Point of care in vitro diagnostics is being applied to an increasingly wide range of applications in infectious disease, cardiovascular, respiratory, and metabolic disease diagnosis and screening. The market is undergoing rapid expansion, primarily due to the demand for COVID-19 testing; however, other product segments will also contribute to market growth during the forecast period.

June 28, 2021

Fracture Fixation Devices Market

This medical market and technology report provides a comprehensive discussion of the global market for fracture fixation devices.

August 5, 2021

Q3 2021 Outlook Report

In this report, we cover catalysts from 27 drugs, devices, diagnostics, and deals expected to occur in the third quarter of 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

June 2, 2021

Transcatheter Heart Valve Repair and Replacement Devices

In 2020, the global market for transcatheter heart valve management products, including transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve (TMV) repair products, totaled nearly $4.7bn, with TAVR products accounting for nearly 90% of sales.

August 30, 2021

Interventional Neurology: Carotid Artery Stents and Embolic Protection Systems

Interventional Cardiology: Carotid Artery Stents and Embolic Protection Systems

This medical market and technology report provides a comprehensive discussion of the global market for carotid artery stents and embolic protection systems. Geographically

September 9, 2021

Liquid Biopsy Oncology Market

This comprehensive medical market and technology report provides an overview and in-depth market analysis of liquid biopsy products used in the field of oncology. In 2020, the global market for liquid biopsy products for oncology applications was valued at approximately $1.9bn.

October 11, 2021

Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration – 2021

This medical market and technology report provides a comprehensive discussion of the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration. Geographic markets covered by this analysis comprise the US, Japan, five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW), which includes all other countries.

November 2, 2021

Drug Delivery: Inhalation Devices

This Meddevicetracker report includes a discussion of inhalation devices, products, current/forecast markets, competitors, and opportunities in the global markets for inhalation-based drug delivery devices for the treatment of asthma and COPD and much more.

December 14, 2021

Interventional Cardiology: Implantable Cardioverter Defibrillators

The ICD market alone lost nearly $1bn from $8.3bn in 2019 to $7.4bn in 2020 due to a combination of lockdowns, supply chain disruptions, and logistical strain in the healthcare space. The global market for ICD devices, along with many other medical devices, is currently recovering from a major economic downturn. Therefore, to provide context as to the nature of this market recovery and what exactly it is recovering from, data from 2019 are included. Types of cardiac defibrillators covered by the scope of this report include ICDs, subcutaneous ICDs (S-ICDs), and cardiac resynchronization therapy defibrillators (CRT-Ds). The regions covered by this report are the US, the 5 major European economies (UK, France, Spain, Italy, Germany), Japan, and the rest of the world. The forecast range is 2020-2025.

December 21, 2021

Interventional Neurology: Cerebral Aneurysm and Arteriovenous Malformation Systems

This medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and AVM embolization systems. This market comprises the following product segments: endovascular coils, liquid embolics, stents for stent-assisted coiling, flow diversion and flow disruption systems, and other novel/emerging embolization devices. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets. The forecast range for this report is 2020–25.

December 16, 2021

Digital Health Technology and Regulatory Overview

This technology report provides an overview of the current landscape for digital health devices and software. This includes a summary of regulation and reimbursement policies and highlights of major product categories.

December 13, 2021

Bone Grafts and Substitutes

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for bone grafts and substitutes. Product segments covered by this report include allografts and synthetic bone substitutes, growth factors, and cellular bone matrices.

February 15, 2022

Drug Delivery: Injection Devices

Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is commonly regarded as the most accurate, effective, reliable, and reproducible method of therapeutic drug and fluid delivery. In 2021, combined sales of the injection devices covered by this report totaled nearly $5.7bn.

March 15, 2022

Interventional Neurology: Mechanical Thrombectomy Devices

Mechanical thrombectomy (MT) is an emergency surgical technique used in eligible patients experiencing acute ischemic stroke (AIS) to remove a blood clot in the brain. In 2021, the combined global market for neuroendovascular MT devices was estimated at approximately $706m.

June 14, 2022

European Markets for Spinal Motion-Preserving Devices

This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the European market for nonfusion spinal technologies for the treatment of degenerative disc disease.

September 22, 2016

Germany, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Germany.

October 1, 2013

France, Disease Incidence and Prevalence

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry.

September 22, 2016

United Kingdom, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union member state of the U.K.

September 22, 2016

Spain, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Spain.

November 1, 2013

France, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the EU country of France.

August 1, 2013

Asia-Pacific Disease Incidence and Prevalence

$5,250.00

The Asia-Pacific (APAC) region is a part of the world which includes several developing and developed countries. Countries covered in this report include Australia, China, India, Japan, Malaysia, South Korea, Thailand, and Vietnam.

January 1, 2016